Literature DB >> 25271595

Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress.

Xia Hua1, Zhitao Su, Ruzhi Deng, Jing Lin, De-Quan Li, Stephen C Pflugfelder.   

Abstract

PURPOSE: To explore the effects of osmoprotectants on pro-inflammatory mediator production in primary human corneal epithelial cells (HCECs) exposed to hyperosmotic stress.
METHODS: HCECs cultured in iso-osmolar medium (312 mOsM) were switched to hyperosmotic media with or without prior incubation with 2-20 mM of l-carnitine, erythritol or betaine for different time periods. The mRNA expression and protein production of pro-inflammatory markers in HCECs were evaluated by RT-qPCR and ELISA.
RESULTS: Hyperosmolar media significantly stimulated the mRNA and protein expression of pro-inflammatory cytokines, TNF-α, IL-1β and IL-6, and chemokines, IL-8, CCL2 and CCL20 in HCECs in an osmolarity dependent manner. The stimulated expression of these pro-inflammatory mediators was significantly but differentially suppressed by l-carnitine, erythritol or betaine. l-Carnitine displayed the greatest inhibitory effects and down-regulated 54-77% of the stimulated mRNA levels of TNF-α (down from 12.3-5.7 fold), IL-1β (2.2-0.9 fold), IL-6 (7.3-2.9 fold), IL-8 (4.6-2.0 fold), CCL2 (15.3-3.5 fold) and CCL20 (4.1-1.5 fold) in HCECs exposed to 450 mOsM. The stimulated protein production of TNF-α, IL-1β, IL-6 and IL-8 was also significantly suppressed by l-carnitine, erythritol and betaine. l-carnitine suppressed 49-79% of the stimulated protein levels of TNF-α (down from 81.3 to 17.4 pg/ml), IL-1β (56.9-29.2 pg/ml), IL-6 (12.8-4.6 ng/ml) and IL-8 (21.2-10.9 ng/ml) by HCECs exposed to 450 mOsM. Interestingly, hyperosmolarity stimulated increase in mRNA and protein levels of TNF-α, IL-1β and IL-6 were significantly suppressed by a transient receptor potential vanilloid channel type 1 (TRPV1) activation inhibitor capsazepine.
CONCLUSIONS: l-carnitine, erythritol and betaine function as osmoprotectants to suppress inflammatory responses via TRPV1 pathway in HCECs exposed to hyperosmotic stress. Osmoprotectants may have efficacy in reducing innate inflammation in dry eye disease.

Entities:  

Keywords:  Corneal epithelial cells; chemokines; hyperosmolarity; osmoprotectant; pro-inflammatory cytokines

Mesh:

Substances:

Year:  2014        PMID: 25271595      PMCID: PMC4793974          DOI: 10.3109/02713683.2014.957776

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  67 in total

1.  Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.

Authors:  F Brignole; P J Pisella; M Goldschild; M De Saint Jean; A Goguel; C Baudouin
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-05       Impact factor: 4.799

2.  Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva; Louis Tong; Lihui Luo; Michael E Stern; De-Quan Li
Journal:  Ocul Surf       Date:  2005-10       Impact factor: 5.033

3.  Morphologic effect of hyperosmolarity on rabbit corneal epithelium.

Authors:  J P Gilbard; J B Carter; D N Sang; M F Refojo; L A Hanninen; K R Kenyon
Journal:  Ophthalmology       Date:  1984-10       Impact factor: 12.079

Review 4.  Evaluation and differential diagnosis of keratoconjunctivitis sicca.

Authors:  M A Lemp
Journal:  J Rheumatol Suppl       Date:  2000-12

5.  Impact of dry eye syndrome on vision-related quality of life.

Authors:  Biljana Miljanović; Reza Dana; David A Sullivan; Debra A Schaumberg
Journal:  Am J Ophthalmol       Date:  2007-01-02       Impact factor: 5.258

6.  Potential nutritional and physiological functions of betaine in livestock.

Authors:  M Eklund; E Bauer; J Wamatu; R Mosenthin
Journal:  Nutr Res Rev       Date:  2005-06       Impact factor: 7.800

Review 7.  Prevalence, burden, and pharmacoeconomics of dry eye disease.

Authors:  Stephen C Pflugfelder
Journal:  Am J Manag Care       Date:  2008-04       Impact factor: 2.229

8.  Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells.

Authors:  Megan E Cavet; Karen L Harrington; Keith W Ward; Jin-Zhong Zhang
Journal:  Mol Vis       Date:  2010-09-02       Impact factor: 2.367

9.  A possible role of ProP, ProU and CaiT in osmoprotection of Escherichia coli by carnitine.

Authors:  A Verheul; J A Wouters; F M Rombouts; T Abee
Journal:  J Appl Microbiol       Date:  1998-12       Impact factor: 3.772

Review 10.  Primary and secondary carnitine deficiency syndromes.

Authors:  R Pons; D C De Vivo
Journal:  J Child Neurol       Date:  1995-11       Impact factor: 1.987

View more
  25 in total

1.  Matrix regeneration agents improve wound healing in non-stressed human corneal epithelial cells.

Authors:  A Robciuc; R P J Arvola; M Jauhiainen; J M Holopainen
Journal:  Eye (Lond)       Date:  2017-12-22       Impact factor: 3.775

2.  Transient tear hyperosmolarity disrupts the neuroimmune homeostasis of the ocular surface and facilitates dry eye onset.

Authors:  Mauricio Guzmán; Maximiliano Miglio; Irene Keitelman; Carolina Maiumi Shiromizu; Florencia Sabbione; Federico Fuentes; Analía S Trevani; Mirta N Giordano; Jeremías G Galletti
Journal:  Immunology       Date:  2020-08-14       Impact factor: 7.397

3.  Hyperosmolarity disrupts tight junction via TNF-α/MMP pathway in primary human corneal epithelial cells.

Authors:  Yun Zhang; Ming Yang; Shi-Xin Zhao; Li Nie; Li-Jun Shen; Wei Han
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

4.  Protective Effects of L-Carnitine Against Oxidative Injury by Hyperosmolarity in Human Corneal Epithelial Cells.

Authors:  Xia Hua; Ruzhi Deng; Jin Li; Wei Chi; Zhitao Su; Jing Lin; Stephen C Pflugfelder; De-Quan Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

5.  IL-36α/IL-36RA/IL-38 signaling mediates inflammation and barrier disruption in human corneal epithelial cells under hyperosmotic stress.

Authors:  Jin-Miao Li; Rong Lu; Yun Zhang; Jing Lin; Xia Hua; Stephen C Pflugfelder; De-Quan Li
Journal:  Ocul Surf       Date:  2021-08-21       Impact factor: 6.268

6.  Anti-inflammatory effects of paeoniflorin from Paeonia lactiflora Pall. on human corneal epithelial cells and a mouse model of dry eye disease.

Authors:  Mincong Zhao; Li Liu; Yating Zheng; Guangrong Liu; Biao Che; Penghui Li; Huixiong Chen; Changzhi Dong; Li Lin; Zhiyun Du
Journal:  RSC Adv       Date:  2019-04-29       Impact factor: 4.036

7.  In Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human HeLa-Modified Conjunctiva-Derived Cells.

Authors:  Elise Warcoin; Christophe Baudouin; Carole Gard; Françoise Brignole-Baudouin
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

8.  Topical Delivery of Levocarnitine to the Cornea and Anterior Eye by Thermosensitive in-situ Gel for Dry Eye Disease.

Authors:  Baorui Ma; Linnuo Pang; Pingqing Huang; Jie Bai; Zhiqin Zhang; Huimin Wu; Mengru Cai; Jin Yang; Yuchen Xu; Xingbin Yin; Changhai Qu; Jian Ni
Journal:  Drug Des Devel Ther       Date:  2021-06-02       Impact factor: 4.162

9.  In Vivo and Impression Cytology Study on the Effect of Compatible Solutes Eye Drops on the Ocular Surface Epithelial Cell Quality in Dry Eye Patients.

Authors:  Manuela Lanzini; Claudia Curcio; Rossella Annamaria Colabelli-Gisoldi; Alessandra Mastropasqua; Roberta Calienno; Luca Agnifili; Mario Nubile; Leonardo Mastropasqua
Journal:  Mediators Inflamm       Date:  2015-06-29       Impact factor: 4.711

Review 10.  Polymodal roles of transient receptor potential channels in the control of ocular function.

Authors:  Peter S Reinach; Weiwei Chen; Stefan Mergler
Journal:  Eye Vis (Lond)       Date:  2015-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.